{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:46:12Z","timestamp":1785105972243,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"GW4 BioMed Research Council"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009745","name":"Royal Devon and Exeter NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009745","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cardiopulmonary exercise testing (CPET) is feasible, valid, reliable, and clinically useful in interstitial lung disease (ILD). However, maximal CPET values are often presented relative to body mass, whereas fat-free mass (FFM) may better reflect metabolically active muscle during exercise. Moreover, despite the value of maximal parameters, people with ILD do not always exercise maximally and therefore clinically relevant submaximal parameters must be identified. Therefore, this study assessed peak oxygen uptake (VO<jats:sub>2peak<\/jats:sub>) relative to FFM, identifying the validity of common scaling techniques; as well as characterising the oxygen uptake efficiency slope (OUES) and plateau (OUEP) as possible submaximal parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Participants with ILD underwent assessment of body composition and CPET via cycle ergometry during a single study visit. To determined effectiveness of scaling for body size, both body mass and FFM were scaled using ratio-standard (X\/Y) and allometric (X\/Y<jats:sup>b<\/jats:sup>) techniques. Pearsons\u2019s correlations determined agreement between OUES, OUEP, and parameters of lung function. Cohens kappa (\u03ba) assessed agreement between OUES, OUEP and VO<jats:sub>2peak<\/jats:sub>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 24 participants (7 female; 69.8\u2009\u00b1\u20097.5 years; 17 with idiopathic pulmonary fibrosis) with ILD completed the study. Maximal exercise parameters did not require allometric scaling, and when scaled to FFM, it was shown that women have a significantly higher VO<jats:sub>2peak<\/jats:sub> than men (<jats:italic>p<\/jats:italic>\u2009=\u20090.044). Results also indicated that OUEP was significantly and positively correlated with DL<jats:sub>CO<\/jats:sub> (<jats:italic>r<\/jats:italic>\u2009=\u20090.719, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and held moderate agreement with VO<jats:sub>2peak<\/jats:sub> (\u03ba\u2009=\u20090.50, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study identified that ratio-standard scaling is sufficient in removing residual effects of body size from VO<jats:sub>2peak<\/jats:sub>, and that VO<jats:sub>2peak<\/jats:sub> is higher in women when FFM is considered. Encouragingly, this study also identified OUEP as a possible alternative submaximal marker in people with ILD, and thus warrants further examination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12931-025-03195-9","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T02:41:58Z","timestamp":1743734518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Body composition, maximal fitness, and submaximal exercise function in people with interstitial lung disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Owen W.","family":"Tomlinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Duckworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Wollerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Scotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-6248","authenticated-orcid":false,"given":"Craig A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"3","key":"3195_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1164\/rccm.200503-483OE","volume":"172","author":"TE King Jr","year":"2005","unstructured":"King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005;172(3):268\u201379.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10053","key":"3195_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"T Vos","year":"2016","unstructured":"Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and National incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545\u2013602.","journal-title":"Lancet"},{"issue":"10053","key":"3195_CR3","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"H Wang","year":"2016","unstructured":"Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and National life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459\u2013544.","journal-title":"Lancet"},{"key":"3195_CR4","unstructured":"British Thoracic Society. BTS ILD Registry Annual Report 2019. London, UK: British Thoracic Society; 2019."},{"issue":"3","key":"3195_CR5","doi-asserted-by":"publisher","first-page":"00027","DOI":"10.1183\/23120541.00027-2020","volume":"6","author":"SL Barratt","year":"2020","unstructured":"Barratt SL, Davis R, Sharp C, Pauling JD. The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review. ERJ Open Res. 2020;6(3):00027\u20132020.","journal-title":"ERJ Open Res"},{"key":"3195_CR6","doi-asserted-by":"crossref","unstructured":"Pugashetti J, Graham J, Boctor N, Mendez C, Foster E, Juarez M et al. Weight loss as a predictor of mortality in patients with interstitial lung disease. Eur Respir J. 2018;52(3).","DOI":"10.1183\/13993003.01289-2018"},{"issue":"3","key":"3195_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/resp.12941","volume":"22","author":"O Nishiyama","year":"2017","unstructured":"Nishiyama O, Yamazaki R, Sano H, Iwanaga T, Higashimoto Y, Kume H, et al. Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosis. Respirology. 2017;22(3):480\u20135.","journal-title":"Respirology"},{"issue":"6","key":"3195_CR8","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1378\/chest.127.6.2028","volume":"127","author":"O Nishiyama","year":"2005","unstructured":"Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, et al. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest. 2005;127(6):2028\u201333.","journal-title":"Chest"},{"issue":"1","key":"3195_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12931-019-1019-9","volume":"20","author":"SA Guler","year":"2019","unstructured":"Guler SA, Hur SA, Lear SA, Camp PG, Ryerson CJ. Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study. Respir Res. 2019;20(1):56.","journal-title":"Respir Res"},{"issue":"11","key":"3195_CR10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/thx.2006.062836","volume":"61","author":"J Gribbin","year":"2006","unstructured":"Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006;61(11):980\u20135.","journal-title":"Thorax"},{"issue":"10","key":"3195_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684\u201391.","journal-title":"Ann Intern Med"},{"issue":"4","key":"3195_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1378\/chest.13-1474","volume":"145","author":"CJ Ryerson","year":"2014","unstructured":"Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014;145(4):723\u20138.","journal-title":"Chest"},{"issue":"5","key":"3195_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1164\/rccm.200802-241OC","volume":"179","author":"CD Fell","year":"2009","unstructured":"Fell CD, Liu LX, Motika C, Kazerooni EA, Gross BH, Travis WD, et al. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179(5):402\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"3195_CR14","doi-asserted-by":"publisher","first-page":"514817","DOI":"10.1155\/2013\/514817","volume":"2013","author":"C Triantafillidou","year":"2013","unstructured":"Triantafillidou C, Manali E, Lyberopoulos P, Kolilekas L, Kagouridis K, Gyftopoulos S, et al. The role of cardiopulmonary exercise test in IPF prognosis. Pulmonary Med. 2013;2013:514817.","journal-title":"Pulmonary Med"},{"issue":"8","key":"3195_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.4187\/respcare.04471","volume":"61","author":"B Vainshelboim","year":"2016","unstructured":"Vainshelboim B, Oliveira J, Fox BD, Kramer MR. The prognostic role of ventilatory inefficiency and exercise capacity in idiopathic pulmonary fibrosis. Respir Care. 2016;61(8):1100\u20139.","journal-title":"Respir Care"},{"issue":"2","key":"3195_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/BF00705066","volume":"65","author":"AM Nevill","year":"1992","unstructured":"Nevill AM, Ramsbottom R, Williams C. Scaling physiological measurements for individuals of different body size. Eur J Appl Physiol Occup Physiol. 1992;65(2):110\u20137.","journal-title":"Eur J Appl Physiol Occup Physiol"},{"issue":"1","key":"3195_CR17","doi-asserted-by":"publisher","first-page":"e000793","DOI":"10.1136\/bmjresp-2020-000793","volume":"8","author":"O Tomlinson","year":"2021","unstructured":"Tomlinson O, Duckworth A, Markham L, Wollerton R, Knight B, Spiers A, et al. Feasibility of cardiopulmonary exercise testing in interstitial lung disease: the PETFIB study. BMJ Open Respiratory Res. 2021;8(1):e000793.","journal-title":"BMJ Open Respiratory Res"},{"issue":"6","key":"3195_CR18","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/jcm11061609","volume":"11","author":"B Stubbe","year":"2022","unstructured":"Stubbe B, Ittermann T, Grieger A, Walther C, Gl\u00e4ser S, Ewert R. Value of cardiopulmonary exercise testing in prognostic assessment of patients with interstitial lung diseases. J Clin Med. 2022;11(6):1609.","journal-title":"J Clin Med"},{"issue":"6","key":"3195_CR19","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/S0735-1097(96)00412-3","volume":"28","author":"R Baba","year":"1996","unstructured":"Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, et al. Oxygen uptake efficiency slope: A new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996;28(6):1567\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3195_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jcf.2010.03.003","volume":"9","author":"M Gruet","year":"2010","unstructured":"Gruet M, Brisswalter J, Mely L, Vallier JM. Clinical utility of the oxygen uptake efficiency slope in cystic fibrosis patients. J Cyst Fibros. 2010;9(5):307\u201313.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"3195_CR21","first-page":"252","volume":"4","author":"A Barron","year":"2016","unstructured":"Barron A, Francis DP, Mayet J, Ewert R, Obst A, Mason M, et al. Oxygen uptake efficiency slope and breathing reserve, not anaerobic threshold, discriminate between patients with cardiovascular disease over chronic obstructive pulmonary disease. JACC: Heart Fail. 2016;4(4):252\u201361.","journal-title":"JACC: Heart Fail"},{"issue":"5","key":"3195_CR22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1378\/chest.11-1270","volume":"141","author":"XG Sun","year":"2012","unstructured":"Sun XG, Hansen JE, Stringer WW. Oxygen uptake efficiency plateau best predicts early death in heart failure. Chest. 2012;141(5):1284\u201394.","journal-title":"Chest"},{"issue":"10","key":"3195_CR23","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00421-018-3926-8","volume":"118","author":"OW Tomlinson","year":"2018","unstructured":"Tomlinson OW, Barker AR, Chubbock LV, Stevens D, Saynor ZL, Oades PJ, et al. Analysis of oxygen uptake efficiency parameters in young people with cystic fibrosis. Eur J Appl Physiol. 2018;118(10):2055\u201363.","journal-title":"Eur J Appl Physiol"},{"issue":"20","key":"3195_CR24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"key":"3195_CR25","unstructured":"National Institute for Health and Care Excellence. Idiopathic pulmonary fibrosis in adults: diagnosis and management [Internet]. London, UK. 2017. Available from: https:\/\/www.nice.org.uk\/guidance\/cg163"},{"issue":"6","key":"3195_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"issue":"Suppl 16","key":"3195_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1183\/09041950.041s1693","volume":"6","author":"JE Cotes","year":"1993","unstructured":"Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J. 1993;6(Suppl 16):41\u201352.","journal-title":"Eur Respir J"},{"issue":"1","key":"3195_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12890-022-02289-0","volume":"22","author":"OW Tomlinson","year":"2022","unstructured":"Tomlinson OW, Markham L, Wollerton RL, Knight BA, Duckworth A, Gibbons MA, et al. Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease. BMC Pulm Med. 2022;22(1):485.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"3195_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","volume":"14","author":"GAV Borg","year":"1982","unstructured":"Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377\u201381.","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"3195_CR30","first-page":"700","volume":"131","author":"NL Jones","year":"1985","unstructured":"Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985;131(5):700\u20138.","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"3195_CR31","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1152\/jappl.1986.60.6.2020","volume":"60","author":"WL Beaver","year":"1986","unstructured":"Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986;60(6):2020\u20137.","journal-title":"J Appl Physiol"},{"issue":"154","key":"3195_CR32","doi-asserted-by":"publisher","first-page":"180101","DOI":"10.1183\/16000617.0101-2018","volume":"28","author":"T Radtke","year":"2019","unstructured":"Radtke T, Crook S, Kaltsakas G, Louvaris Z, Berton D, Urquhart DS, et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respiratory Rev. 2019;28(154):180101.","journal-title":"Eur Respiratory Rev"},{"issue":"10","key":"3195_CR33","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1249\/MSS.0000000000001314","volume":"49","author":"OW Tomlinson","year":"2017","unstructured":"Tomlinson OW, Barker AR, Oades PJ, Williams CA. Scaling the oxygen uptake efficiency slope for body size in cystic fibrosis. Med Sci Sports Exerc. 2017;49(10):1980\u20136.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"3195_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112(1):155\u20139.","journal-title":"Psychol Bull"},{"issue":"1","key":"3195_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37\u201346.","journal-title":"Educ Psychol Meas"},{"issue":"1","key":"3195_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"1","key":"3195_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12890-022-01840-3","volume":"22","author":"M Hanada","year":"2022","unstructured":"Hanada M, Sakamoto N, Ishimoto H, Kido T, Miyamura T, Oikawa M, et al. A comparative study of the sarcopenia screening in older patients with interstitial lung disease. BMC Pulm Med. 2022;22(1):45.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"3195_CR38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12931-022-02159-7","volume":"23","author":"P Faverio","year":"2022","unstructured":"Faverio P, Fumagalli A, Conti S, Madotto F, Bini F, Harari S, et al. Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach. Respir Res. 2022;23(1):228.","journal-title":"Respir Res"},{"issue":"3","key":"3195_CR39","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1590\/S0100-879X2012007500018","volume":"45","author":"AJ Lopes","year":"2012","unstructured":"Lopes AJ, Menezes SLS, Dias CM, Oliveira JF, Mainenti MRM, Guimar\u00e3es FS. Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis. Braz J Med Biol Res. 2012;45(3):256\u201363.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"3195_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12890-019-1015-3","volume":"19","author":"BD Fox","year":"2019","unstructured":"Fox BD, Shostak Y, Pertzov B, Vainshelboim B, Itzhakian S, Terner I, et al. IPF patients are limited by mechanical and not pulmonary-vascular factors\u2013 results of a derivation-validation cohort study. BMC Pulm Med. 2019;19(1):244.","journal-title":"BMC Pulm Med"},{"issue":"9","key":"3195_CR41","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/resp.13639","volume":"24","author":"M Armstrong","year":"2019","unstructured":"Armstrong M, Vogiatzis I. Personalized exercise training in chronic lung diseases. Respirology. 2019;24(9):854\u201362.","journal-title":"Respirology"},{"issue":"6","key":"3195_CR42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00408-019-00282-9","volume":"197","author":"L Hagmeyer","year":"2019","unstructured":"Hagmeyer L, Herkenrath S, Anduleit N, Treml M, Randerath W. Cardiopulmonary exercise testing allows discrimination between idiopathic Non-specific interstitial pneumonia and idiopathic pulmonary fibrosis in mild to moderate stages of the disease. Lung. 2019;197(6):721\u20136.","journal-title":"Lung"},{"issue":"1","key":"3195_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ppul.23896","volume":"53","author":"CA Williams","year":"2018","unstructured":"Williams CA, Tomlinson OW, Chubbock LV, Stevens D, Saynor ZL, Oades PJ, et al. The oxygen uptake efficiency slope is not a valid surrogate of aerobic fitness in cystic fibrosis. Pediatr Pulmonol. 2018;53(1):36\u201342.","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"3195_CR44","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s40279-016-0655-1","volume":"47","author":"L Lolli","year":"2017","unstructured":"Lolli L, Batterham AM, Weston KL, Atkinson G. Size exponents for scaling maximal oxygen uptake in over 6500 humans: A systematic review and meta-analysis. Sports Med. 2017;47(7):1405\u201319.","journal-title":"Sports Med"},{"issue":"1","key":"3195_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331.","journal-title":"Age Ageing"},{"key":"3195_CR46","doi-asserted-by":"crossref","unstructured":"Baglietto N, Vaquero-Crist\u00f3bal R, Albaladejo-Saura M, Mecherques-Carini M, Esparza-Ros F. Assessing skeletal muscle mass and lean body mass: an analysis of the agreement among dual X-ray absorptiometry, anthropometry, and bioelectrical impedance. Front Nutr. 2024;11.","DOI":"10.3389\/fnut.2024.1445892"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03195-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03195-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03195-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T13:03:14Z","timestamp":1751547794000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03195-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3195"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03195-9","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was granted by the Health Research Authority (IRAS #220189) following review by the South West (Frenchay) Research Ethics Committee (17\/SW\/0059). All participants provided written, informed, informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have consented to publication of study data as part of consent to study participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"For the purpose of open access, the authors have applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Rights retention"}},{"value":"This project is supported by the National Institute for Health Research (NIHR) Exeter Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"An abstract associated with this work has been previously published at the British Thoracic Society, with publication in a supplement of Thorax under the following citation: Tomlinson et al. (2021). S14 The utility of the oxygen uptake efficiency plateau as a submaximal exercise biomarker in interstitial lung disease, Thorax, 76 (S1): A11-A12.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}